Japan Biopsy Devices Market Insight
Published: 17 July 2026 | Report Format: Electronic (PDF) | Author: Aditi and Govind
The Japan Biopsy Devices Market will grow at a rate of 6.87% due to rising demand for minimally invasive diagnostic procedures, a growing incidence of cancer among the country's aging population, technological advancements in image-guided biopsy techniques, and the increasing integration of artificial intelligence in pathology workflows across hospitals, specialized oncology centers, and diagnostic laboratories.
Japan Biopsy Devices Market Insights Forecasts to 2035
- The Japan Biopsy Devices Market Size Was Estimated USD 136.2 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.87% from 2025 to 2035
- The Japan Biopsy Devices Market Size is Expected to rise around USD 264.8 Million by 2035
Notable Insights for the Japan Biopsy Devices Market
- Segmentation on the basis of Product Type indicates that Needle-based Biopsy Guns and vacuum-assisted biopsy systems dominate Japan market in 2025 with 43.9% share across oncology clinics and medical imaging center networks.
- Segmentation on the basis of Application indicates that Breast Biopsy and Lung Biopsy segments dominate Japan Biopsy Devices Market 2025 with 48.0% share, driven by specialized screening programs and preventive diagnostic campaigns.
- World-wide projected revenue of Olympus Corporation in fiscal year 2025 would be around $6.4 billion, owing to high demand for endoscopic ultrasound processors, visualization platforms, and advanced surgical instruments.
- It is expected that increasing modernization in radiology departments, precision diagnostic needs, and adoption of digital pathology systems would contribute in driving the growth of the market, where vacuum-assisted biopsies offer precise core tissue extraction up to 34%, and minimize clinical risk of diagnostic errors up to 27%.
Download the eBook (ToC)
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in precision biopsy techniques, modernization in oncology diagnostic infrastructure, and development in image-guided core biopsy technology on the Japan Biopsy Devices Market growth.
- Provides strategic insights regarding technology innovation such as vacuum-assisted tissue extraction, magnetic resonance imaging (MRI)-guided biopsy, robotic navigation systems, and real-time visualization technologies.
- Assists players to analyze competitive benchmarking, investment in molecular diagnostics, automation in clinical procedures, and expansion in specialized outpatient diagnostic units by major biopsy device suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Biopsy Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Biopsy Devices Market
- Olympus Corporation
- Becton, Dickinson and Company (BD Japan)
- Boston Scientific Corporation
- Hologic Inc.
- Medtronic plc
- Fujifilm Healthcare Corporation
- TSK Laboratory Japan
- Argon Medical Devices, Inc.
- Cook Medical
- Taisho Biomed Instruments Co. Ltd.
Recent Developments:
- In January 2026, Olympus Corporation announced the commercial launch of its SecureFlex single-use fine needle biopsy (EUS-FNB) device, which integrates with advanced ultrasound processors to maximize tissue yield and procedural accessibility in anatomically challenging pancreatic and biliary lesions.
- In March 2025, Becton, Dickinson and Company (BD) introduced next-generation automated biopsy guidance technologies featuring real-time needle trajectory visualization, specifically designed to optimize core tissue collection within diagnostic oncology centers throughout Japan.
Market Segmentation:
Japan Biopsy Devices Market, By Product Type
- Needle-Based Biopsy Guns
- Vacuum-Assisted Biopsy (VAB) Devices
- Fine Needle Aspiration Biopsy (FNAB) Devices
- Core Needle Biopsy (CNB) Devices
- Biopsy Forceps & Specialized Needles
Japan Biopsy Devices Market, By Technology
- Ultrasound-Guided Biopsy Systems
- Stereotactic-Guided Biopsy Systems
- MRI-Guided Precision Biopsies
- CT-Guided Navigation Platforms
- Robotic-Assisted Targeting Technologies
Japan Biopsy Devices Market, By Application
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Gynecological & Other Biopsies
Expert Views:
The market for biopsy devices in Japan will grow owing to the rise in the demand for high accuracy diagnostic instruments, the growing number of modernization of healthcare facilities, and increasing demand for minimally invasive diagnostic solutions. The inclusion of artificial intelligence-based localization software, high-resolution ultrasound visualization systems, and ergonomic core biopsy tools will enhance clinical precision and boost the demand for biopsy devices in the Japanese market.
Author: Aditi and Govind By Decisions Advisors and Consulting